Karen Wyckoff Rein In Sarcoma
Karen Wyckoff Rein In Sarcoma maintains strong assets and zero executive compensation, consistently operating with surpluses.
EIN: 200811343 · Fridley, MN · NTEE: H30 · Updated: 2026-03-28
Source Check Matrix
What Has Been Verified vs. What Needs Human Review
Identity resolved verified
Karen Wyckoff Rein In Sarcoma is mapped to EIN 200811343.
IRS BMF exempt record needs review
Open IRS TEOS or BMF source before relying on exemption status.
IRS Pub 78 deductibility needs review
Pub 78 eligibility should be verified in IRS TEOS before money changes hands.
IRS automatic revocation needs review
Check the official auto-revocation bulk source or cached evidence before relying on current exemption.
IRS Form 990 index verified
13 stored filing years available.
Raw 990 source linked
Open ProPublica to verify the raw filing record and PDFs.
Filing depth verified
13 stored filing years available.
State charity registration manual confirmation
Open MN charity regulator via NASCO; the workflow stops for human confirmation unless a stable source is cached.
Candid / GuideStar profile api pending
Candid API access is not configured; open manually and do not count as verified evidence.
Charity Navigator rating api pending
Charity Navigator API access is not configured; open manually and do not count as verified evidence.
Source and Resolution Links
Finish the Investigation Outside Our Dataset
When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.
IRS tax-exempt lookup
Verify exemption status and deductibility directly with the IRS.
IRS bulk evidence downloads
Check Pub 78, automatic revocation, 990-N, and Form 990 bulk evidence sources.
IRS EO BMF extract
Open the official Business Master File extract source for tax-exempt organization records.
ProPublica 990 source
Open the raw filing record and filing PDFs outside NonprofitSpending.
MN charity regulator via NASCO
Confirm state charity registration or solicitation status where applicable.
Candid profile search
Look for GuideStar/Candid profile details, programs, leadership, and seals.
Charity Navigator search
Check whether another evaluator has ratings or impact context.
Workflow Engine
Queries We Should Resolve, Not Just Answer
Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.
Verify tax status Runnable
Triggered by: 501(c)(3), tax deductible, EIN
IRS status check plus source links
Verify official evidence Runnable
Triggered by: IRS Pub 78, BMF, revocation, 990 index, state registration
Official-source evidence matrix with human stops where a state portal must be checked.
Resolve tax deductibility Runnable
Triggered by: is my donation tax deductible, Pub 78, donor receipt
Pub 78, BMF, and revocation checks turned into a donor-safe deductibility path.
Check state solicitation Runnable
Triggered by: allowed to solicit, charity registration, state compliance
Official state regulator route with human confirmation when no reliable API exists.
Find source filings Runnable
Triggered by: 990 PDF, annual report, filing record
13 stored filing years plus ProPublica source
Crunch money signals Runnable
Triggered by: program expense ratio, CEO salary, revenue, grants
85% program spend, health grade A
Compare alternatives Runnable
Triggered by: best charities, similar nonprofits, compare
4 peer options surfaced
Resolve leadership and board Runnable
Triggered by: executive team, trustees, officer pay
Use 990 compensation disclosures and external profile links.
Analyze executive compensation Runnable
Triggered by: CEO salary, excessive compensation, officer pay
Officer-pay context against revenue, filings, state/category compensation, and source records.
Donation decision copilot Runnable
Triggered by: should I donate, give or compare, charity safety
Eligibility, money signals, sources, peer context, and next action.
Grantmaker due diligence Runnable
Triggered by: foundation review, grant risk, grantee capacity
Foundation-style packet across filings, finances, governance, and gaps.
Build grant/funder shortlist Runnable
Triggered by: find funders, grantee shortlist, mission fit
Geography, cause, evidence gaps, and peers converted into a funder/grantee action path.
Impact evidence finder Runnable
Triggered by: outcomes, annual report, cost effectiveness
Separate actual impact evidence from raw 990 financial cleanliness.
Room for more funding Runnable
Triggered by: would my donation help, funding gap, marginal impact
Revenue trend, runway, surplus/deficit, and source follow-ups.
Operator transparency diagnostic Runnable
Triggered by: how does my nonprofit look to donors
Profile, filing, impact, and transparency improvements to earn trust.
Create compliance monitor Runnable
Triggered by: watch new 990, revocation, Pub 78, registration changes
Monitoring plan for IRS status, new filings, revocation signals, and state follow-ups.
| Metric | Value |
|---|---|
| Total Revenue | $1.5M |
| Total Expenses | $554K |
| Program Spending | 85% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $1.2M |
| Transparency Score | 92/100 |
Search Intent Cockpit
Karen Wyckoff Rein In Sarcoma Form 990, Revenue, CEO Pay, and IRS Filing Signals
Karen Wyckoff Rein In Sarcoma is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Karen Wyckoff Rein In Sarcoma in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $606K and expenses of $554K.
Revenue and Expenses
Karen Wyckoff Rein In Sarcoma reported $606K in revenue and $554K in expenses, a surplus of $52K.
Executive Compensation
Top officer compensation appears as $1 in the stored analysis, with context against revenue and expenses below.
Charity Score and Red Flags
92/100 mission score, 0 red flags, and 5 strengths are shown from structured and AI review.
Is Karen Wyckoff Rein In Sarcoma Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
| Program services | $471K (85%) |
Across stored filings, Karen Wyckoff Rein In Sarcoma shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Appears Legitimate | Good filing record; no red flags identified |
| Mission spend | 85% to programs | Excellent |
| Financial durability | Grade A | 13 stored filing years |
| Peer context | Compare with North American Lake Management Society | Minnesota and Category H context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with North American Lake Management Society →All Minnesota nonprofits
All Category H
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Fridley, MN nonprofitsCategory H in Minnesota
Health in Minnesota
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category H spending
Best Category H charities in Minnesota
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Farmington Youth Basketball Association
Farmington, MN · $308K revenue · Score 92/100
Compare side-by-sideAndover Huskies Youth Hockey Association
Andover, MN · $26.7M revenue · Score 90/100
Compare side-by-sideAgate Housing And Services Inc
Minneapolis, MN · $18.6M revenue · Score 90/100
Compare side-by-sideNorth American Lake Management Society
Caledonia, MN · $676K revenue · Score 90/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Research Workflow
Turn this Form 990 profile into a donor-ready report
Request a concise report for Karen Wyckoff Rein In Sarcoma with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.
Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.
Karen Wyckoff Rein In Sarcoma directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Karen Wyckoff Rein In Sarcoma
Karen Wyckoff Rein In Sarcoma (EIN: 200811343) is a nonprofit organization based in Fridley, MN, classified under NTEE code H30. The organization reported total revenue of $1.5M and total assets of $1.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Karen Wyckoff Rein In Sarcoma's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Karen Wyckoff Rein In Sarcoma is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 10.4%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $606K |
| Total Expenses | $554K |
| Surplus / Deficit | +$52K |
| Total Assets | $1.2M |
| Total Liabilities | $15K |
| Net Assets | $1.2M |
| Operating Margin | 8.6% |
| Debt-to-Asset Ratio | 1.3% |
| Months of Reserves | 25.4 months |
Financial Health Grade: A
In 2023, Karen Wyckoff Rein In Sarcoma reported a surplus of $52K with revenue exceeding expenses, holds 25.4 months of operating reserves (strong position), has a debt-to-asset ratio of 1.3% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Karen Wyckoff Rein In Sarcoma's revenue has grown at a compound annual growth rate (CAGR) of 10.4%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -15.4% | -24.7% | -1.9% |
| 2022 | -24.9% | +36.4% | -2.0% |
| 2021 | +114.2% | +10.5% | +54.0% |
| 2020 | -22.4% | +2.6% | -1.6% |
| 2019 | +34.2% | -1.6% | +13.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Karen Wyckoff Rein In Sarcoma with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Karen Wyckoff Rein In Sarcoma allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $52K, with revenue exceeding expenses.
- Debt-to-asset ratio: 1.3%.
Executive Compensation Analysis
Executive compensation is consistently reported at 0% across all available filings, indicating that no officers receive salaries from the organization, which is highly commendable for an organization of its size with over $1 million in assets.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Karen Wyckoff Rein In Sarcoma:
- Consistent 0% officer compensation, indicating high efficiency and dedication to mission.
- Strong asset growth from $387,852 in 2014 to $1,175,955 in 2023.
- Generally operates with a financial surplus, contributing to asset accumulation (e.g., $51,871 surplus in 2023).
- Consistent IRS 990 filing history (13 filings), demonstrating transparency.
- Low liabilities relative to assets, indicating strong financial solvency (e.g., $15,280 liabilities vs. $1,175,955 assets in 2023).
Frequently Asked Questions about Karen Wyckoff Rein In Sarcoma
Is Karen Wyckoff Rein In Sarcoma a legitimate charity?
Karen Wyckoff Rein In Sarcoma (EIN: 200811343) is a registered tax-exempt nonprofit based in Minnesota. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $1.5M. No red flags identified. 5 strengths noted. Financial health grade: A.
How does Karen Wyckoff Rein In Sarcoma spend its money?
Karen Wyckoff Rein In Sarcoma directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Karen Wyckoff Rein In Sarcoma tax-deductible?
Karen Wyckoff Rein In Sarcoma is registered as a tax-exempt nonprofit (EIN: 200811343). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Karen Wyckoff Rein In Sarcoma CEO make?
Karen Wyckoff Rein In Sarcoma's highest-compensated officer earns $1 annually. The organization reported $1.5M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Karen Wyckoff Rein In Sarcoma's spending goes to programs?
Karen Wyckoff Rein In Sarcoma directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Karen Wyckoff Rein In Sarcoma compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), Karen Wyckoff Rein In Sarcoma is above average for NTEE category H30 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Karen Wyckoff Rein In Sarcoma located?
Karen Wyckoff Rein In Sarcoma is headquartered in Fridley, Minnesota and files with the IRS under EIN 200811343. It is classified under NTEE code H30.
How many years of IRS 990 filings does Karen Wyckoff Rein In Sarcoma have?
Karen Wyckoff Rein In Sarcoma has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.5M in total revenue.
Is Karen Wyckoff Rein In Sarcoma a good charity?
Based on its financial data, Karen Wyckoff Rein In Sarcoma appears to be a very good charity. It consistently reports 0% officer compensation, maintains a healthy asset base, and generally operates with a surplus, indicating efficient use of funds and strong financial management.
How has the organization's revenue trended over time?
The organization's revenue has shown significant growth over the past decade, increasing from $239,134 in 2014 to $606,354 in 2023, with a peak of $954,475 in 2021, demonstrating strong fundraising capabilities.
What is the organization's asset growth like?
Karen Wyckoff Rein In Sarcoma has experienced substantial asset growth, increasing from $387,852 in 2014 to $1,175,955 in 2023, indicating effective financial stewardship and accumulation of resources.
Filing History
IRS 990 filing history for Karen Wyckoff Rein In Sarcoma showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Karen Wyckoff Rein In Sarcoma's revenue has grown by 228.1%, moving from $185K to $606K. Total assets increased by 450.7% over the same period, from $214K to $1.2M. Total functional expenses rose by 192.6%, from $190K to $554K. In its most recent filing year (2023), Karen Wyckoff Rein In Sarcoma reported a surplus of $52K, with revenue exceeding expenses. The organization holds $15K in liabilities against $1.2M in assets (debt-to-asset ratio: 1.3%), resulting in net assets of $1.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $606K | $554K | $1.2M | $15K | — | — |
| 2022 | $717K | $737K | $1.2M | $90K | — | View 990 |
| 2021 | $954K | $540K | $1.2M | $17K | — | View 990 |
| 2020 | $446K | $489K | $795K | $0 | — | View 990 |
| 2019 | $575K | $476K | $808K | $2K | — | View 990 |
| 2018 | $428K | $484K | $710K | $2K | — | View 990 |
| 2017 | $489K | $401K | $774K | $3K | — | — |
| 2016 | $422K | $207K | $683K | $0 | — | View 990 |
| 2015 | $258K | $178K | $468K | $0 | — | View 990 |
| 2014 | $239K | $176K | $388K | $0 | — | View 990 |
| 2013 | $262K | $131K | $325K | $0 | — | View 990 |
| 2012 | $155K | $167K | $195K | $0 | — | View 990 |
| 2011 | $185K | $190K | $214K | $8K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $606K, expenses of $554K, and assets of $1.2M (revenue -15.4% year-over-year).
- 2022: Revenue of $717K, expenses of $737K, and assets of $1.2M (revenue -24.9% year-over-year).
- 2021: Revenue of $954K, expenses of $540K, and assets of $1.2M (revenue +114.2% year-over-year).
- 2020: Revenue of $446K, expenses of $489K, and assets of $795K (revenue -22.4% year-over-year).
- 2019: Revenue of $575K, expenses of $476K, and assets of $808K (revenue +34.2% year-over-year).
- 2018: Revenue of $428K, expenses of $484K, and assets of $710K (revenue -12.5% year-over-year).
- 2017: Revenue of $489K, expenses of $401K, and assets of $774K (revenue +16.0% year-over-year).
- 2016: Revenue of $422K, expenses of $207K, and assets of $683K (revenue +63.1% year-over-year).
- 2015: Revenue of $258K, expenses of $178K, and assets of $468K (revenue +8.1% year-over-year).
- 2014: Revenue of $239K, expenses of $176K, and assets of $388K (revenue -8.6% year-over-year).
- 2013: Revenue of $262K, expenses of $131K, and assets of $325K (revenue +68.2% year-over-year).
- 2012: Revenue of $155K, expenses of $167K, and assets of $195K (revenue -15.9% year-over-year).
- 2011: Revenue of $185K, expenses of $190K, and assets of $214K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Karen Wyckoff Rein In Sarcoma:
Data Sources and Methodology
This transparency report for Karen Wyckoff Rein In Sarcoma is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.